Ablij HC, Meinders AE (2002) C-reactive protein: history and revival. Eur J Intern Med 13(7):412–422
Article CAS PubMed Google Scholar
Agostinis-Sobrinho C, Vicente SE, Norkiene S, Rauckienė-Michaelsson A, Kievisienė J, Dubey VP, Razbadauskas A, Lopes L, Santos R (2022) Is the leptin/adiponectin ratio a better diagnostic biomarker for insulin resistance than leptin or adiponectin alone in adolescents? Children 9(8):1193
Article PubMed PubMed Central Google Scholar
Alfaddagh A, Martin SS, Leucker TM, Michos ED, Blaha MJ, Lowenstein CJ, Jones SR, Toth PP (2020) Inflammation and cardiovascular disease: From mechanisms to therapeutics. Am J Prevent Cardiol. 4:100130
Altman R, Marcussen KC (2001) Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44(11):2531–2538
Article CAS PubMed Google Scholar
Ammon HP (2006) Boswellic acids in chronic inflammatory diseases. Planta Med 72(12):1100–1116
Article CAS PubMed Google Scholar
Arici M, Walls J (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 59(2):407–414
Article CAS PubMed Google Scholar
Azeez TB, Lunghar J (2021) Antiinflammatory effects of turmeric (Curcuma longa) and ginger (Zingiber officinale). Inflam Nat Prod 1:83–102
Badimon L, Peña E, Arderiu G, Padró T, Slevin M, Vilahur G, Chiva-Blanch G (2018) C-reactive protein in atherothrombosis and angiogenesis. Front Immunol 2(9):430. https://doi.org/10.3389/fimmu.2018.00430
Bălănescu AR, Bojincă VC, Bojincă M, Donisan T, Bălănescu SM (2019) Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases. Exp Ther Med 17(2):1024–1029
Banait T, Wanjari A, Danade V, Banait S, Jain J (2022) Role of high-sensitivity C-reactive protein (Hs-CRP) in non-communicable diseases: a review. Cureus. https://doi.org/10.7759/cureus.30225
Article PubMed PubMed Central Google Scholar
Bansal T, Pandey A, Deepa D, Asthana AK (2014) C-reactive protein (CRP) and its association with periodontal disease: a brief review. J Clin Diagnos Res JCDR. https://doi.org/10.7860/JCDR/2014/8355.4646
Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27(2):206–213
Article CAS PubMed PubMed Central Google Scholar
Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96(9):939–949
Article CAS PubMed Google Scholar
Bharadwaj D, Stein MP, Volzer M, Mold C, Clos TW (1999) The major receptor for C-reactive protein on leukocytes is Fcγ receptor II. J Exp Med 190(4):585–590
Article CAS PubMed PubMed Central Google Scholar
Biswas I, Khan GA (2020) Endothelial dysfunction in cardiovascular diseases. Basic Clin Underst Microcirc 22:10
Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279(47):48487–48490
Article CAS PubMed Google Scholar
Bogaty P, Brophy JM, Noel M, Boyer L, Simard S, Bertrand F, Dagenais GR (2004) Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation 110(8):934–939
Article CAS PubMed Google Scholar
Bøhn SK, Ward NC, Hodgson JM, Croft KD (2012) Effects of tea and coffee on cardiovascular disease risk. Food Funct 3(6):575–591
Boroumand N, Samarghandian S, Hashemy SI (2018) Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin. J Herbmed Pharmacol 7(4):211–219
Brophy JM (2005) Celecoxib and cardiovascular risks. Expert Opin Drug Saf 4(6):1005–1015
Article CAS PubMed Google Scholar
Cannon CP, Chen C, Curtis SP, Viscusi J, Ahmed T, DiBattiste PM (2008) A comparison of cardiovascular biomarkers in patients treated for three months with etoricoxib, celecoxib, ibuprofen, and placebo. Arch Drug Inf 1(1):4–13
Article CAS PubMed PubMed Central Google Scholar
Cardoso IL, Paulos AT (2017) C reactive protein and cardiovascular disease. Int Arch Cardiovasc Dis 1(1):1–1
Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C (2018) Immunomodulators inspired by nature: a review on curcumin and echinacea. Molecules 23(11):2778
Article PubMed PubMed Central Google Scholar
Chandran B, Goel A (2012) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 26(11):1719–1725
Article CAS PubMed Google Scholar
Chattopadhyay A (2020) The adverse effects of corticosteroids. Eur J Sports Exerc Sci 9(3):25–32
Choe JY, Kim SK (2015) Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide. Clin Chim Acta 1(438):29–34
Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA (2004) Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Clin Exp Allergy 34(6):891–896. https://doi.org/10.1111/j.1365-2222.2004.01970.x
Article CAS PubMed Google Scholar
Clyne B, Olshaker JS (1999) The C-reactive protein. J Emerg Med 17(6):1019–1025
Article CAS PubMed Google Scholar
Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316–1322
Dale J, Alcorn N, Capell H, Madhok R (2007) Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs. Nat Clin Pract Rheumatol 3(8):450–458
Article CAS PubMed Google Scholar
Davies NM, McLachlan AJ, Day RO, Williams KM (2000) Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 38:225–242
Article CAS PubMed Google Scholar
DeMizio DJ, Geraldino-Pardilla LB (2020) Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis. Rheumatol Therapy 7(1):19–33
Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7:1
Dixit KS, Kumthekar PU (2020) Optimal management of corticosteroids in patients with intracranial malignancies. Curr Treat Options Oncol 21:1–1
Du Clos TW (2000) Function of C-reactive protein. Ann Med 32(4):274–278
Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 1(48):111–136
Comments (0)